PubMed Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH (2011)
Clinical supervision is critical for safety, appropriate titration, and side effect management
The downside is that the same slowing can affect GI motility throughout the tract, contributing to nausea, constipation, and bloating, particularly in the first weeks of a new dose
Lilly has strong growth fundamentals: 54% revenue growth, dominance in the $150B+ GLP-1 market, and a robust pipeline including orforglipron and retatrutide
Side effects : Reported side effects are generally mild - injection site irritation, occasional nausea with oral dosing
This is particularly true for people who experience limited sun exposure, including people who use cosmetics with UV filters or sunscreen